Biotech Startup QurAlis Gains $5.5 Million in Seed Round
November 26, 2018
1:48 pm
QurAlis Corporation, a biotech company focused on developing precision therapeutics for amyotrophic lateral sclerosis (ALS) and other neurological diseases, raised a seed extension that brings the total funding to date to $5.5 million. BioInnovation Capital and Viva Biotech Limited join existing biotech investors MP Healthcare